BlackRock’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$671M Sell
36,411,704
-2,448,797
-6% -$45.2M 0.01% 850
2025
Q1
$679M Buy
38,860,501
+1,840,162
+5% +$32.1M 0.01% 829
2024
Q4
$641M Buy
37,020,339
+1,423,019
+4% +$24.6M 0.01% 915
2024
Q3
$662M Buy
35,597,320
+1,210,446
+4% +$22.5M 0.01% 871
2024
Q2
$530M Buy
34,386,874
+188,609
+0.6% +$2.9M 0.01% 962
2024
Q1
$505M Sell
34,198,265
-269,944
-0.8% -$3.99M 0.01% 1025
2023
Q4
$492M Buy
34,468,209
+1,139,125
+3% +$16.3M 0.01% 1019
2023
Q3
$465M Buy
33,329,084
+180,359
+0.5% +$2.51M 0.01% 946
2023
Q2
$390M Buy
33,148,725
+486,114
+1% +$5.72M 0.01% 1105
2023
Q1
$376M Sell
32,662,611
-69,582
-0.2% -$800K 0.01% 1104
2022
Q4
$407M Buy
32,732,193
+655,198
+2% +$8.14M 0.01% 1020
2022
Q3
$421M Sell
32,076,995
-398,115
-1% -$5.22M 0.01% 913
2022
Q2
$454M Buy
32,475,110
+11,626
+0% +$162K 0.01% 915
2022
Q1
$483M Sell
32,463,484
-741,115
-2% -$11M 0.01% 1006
2021
Q4
$450M Buy
33,204,599
+2,066,288
+7% +$28M 0.01% 1105
2021
Q3
$458M Buy
31,138,311
+59,098
+0.2% +$870K 0.01% 1046
2021
Q2
$566M Buy
31,079,213
+637,071
+2% +$11.6M 0.02% 925
2021
Q1
$528M Buy
30,442,142
+1,292,607
+4% +$22.4M 0.02% 949
2020
Q4
$506M Buy
29,149,535
+919,957
+3% +$16M 0.02% 881
2020
Q3
$389M Sell
28,229,578
-452,937
-2% -$6.24M 0.01% 892
2020
Q2
$414M Sell
28,682,515
-458,418
-2% -$6.61M 0.02% 832
2020
Q1
$318M Buy
29,140,933
+1,419,838
+5% +$15.5M 0.02% 860
2019
Q4
$592M Buy
27,721,095
+1,101,341
+4% +$23.5M 0.02% 696
2019
Q3
$611M Buy
26,619,754
+1,341,510
+5% +$30.8M 0.03% 627
2019
Q2
$498M Sell
25,278,244
-251,661
-1% -$4.96M 0.02% 742
2019
Q1
$497M Buy
25,529,905
+63,064
+0.2% +$1.23M 0.02% 734
2018
Q4
$420M Sell
25,466,841
-108,007
-0.4% -$1.78M 0.02% 745
2018
Q3
$591M Buy
25,574,848
+34,048
+0.1% +$787K 0.03% 661
2018
Q2
$555M Sell
25,540,800
-606,028
-2% -$13.2M 0.03% 663
2018
Q1
$461M Buy
26,146,828
+577,060
+2% +$10.2M 0.02% 746
2017
Q4
$480M Buy
25,569,768
+1,673,758
+7% +$31.4M 0.02% 724
2017
Q3
$524M Buy
23,896,010
+14,325,578
+150% +$314M 0.03% 633
2017
Q2
$231M Buy
9,570,432
+277,421
+3% +$6.69M 0.01% 1172
2017
Q1
$260M Buy
9,293,011
+9,193,585
+9,247% +$257M 0.01% 1071
2016
Q4
$2.43M Buy
99,426
+12,711
+15% +$310K ﹤0.01% 1138
2016
Q3
$2.18M Buy
86,715
+5,327
+7% +$134K ﹤0.01% 1150
2016
Q2
$1.68M Buy
81,388
+18,548
+30% +$383K ﹤0.01% 1216
2016
Q1
$1.26M Buy
62,840
+5,433
+9% +$109K ﹤0.01% 1250
2015
Q4
$1.16M Sell
57,407
-197
-0.3% -$3.98K ﹤0.01% 1246
2015
Q3
$1.34M Buy
57,604
+5,065
+10% +$117K ﹤0.01% 1170
2015
Q2
$1.35M Sell
52,539
-4,940
-9% -$127K ﹤0.01% 1219
2015
Q1
$1.91M Buy
57,479
+9,261
+19% +$307K ﹤0.01% 1089
2014
Q4
$1.46M Buy
48,218
+5,634
+13% +$171K ﹤0.01% 1116
2014
Q3
$1.04M Buy
42,584
+2,753
+7% +$67K ﹤0.01% 1177
2014
Q2
$1.14M Buy
39,831
+9,991
+33% +$287K ﹤0.01% 1144
2014
Q1
$832K Buy
29,840
+1,319
+5% +$36.8K ﹤0.01% 1230
2013
Q4
$745K Buy
28,521
+4,910
+21% +$128K ﹤0.01% 1220
2013
Q3
$543K Buy
23,611
+2,706
+13% +$62.2K ﹤0.01% 1219
2013
Q2
$545K Buy
+20,905
New +$545K ﹤0.01% 1191